Bausch Health Companies | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Amgen USD 1.69B 191M 2025-03
ANI Pharmaceuticals USD 69.72M 9.36M 2024-12
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bausch Health Companies USD 867M 47M 2025-03
Biogen USD 572.5M 104.8M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Danaher USD 1.86B 165M 2025-03
Drreddys Laboratories INR 21.59B 436M 2024-12
Eli Lilly USD 2.36B 62.3M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
Novo Nordisk 16.11B 480M 2025-03
Pacira USD 79.61M 5.28M 2024-12
Perrigo USD 281.2M 46.4M 2025-03
Prestige Brands USD 64.13M 3.35M 2024-12
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Zoetis USD 563M 62M 2025-03



Bausch Health Companies Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.